Showing results (711-720 of 2,002) with videos related to
Sort By:
Pageof 201
Endocrine, Metabolic & Immune Disorders Drug Targets|October 7, 2010
Isoforms of vitamin E differentially regulate inflammationJoan M Cook-Mills, Christine A McCaryEndocrine, Metabolic & Immune Disorders Drug Targets|October 7, 2010
PKC-θ is a drug target for prevention of T cell-mediated autoimmunity and allograft rejectionMyung-Ja Kwon, Ruiqing Wang, Jian Ma, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|October 7, 2010
Wound-associated skin fibrosis: mechanisms and treatments based on modulating the inflammatory responseTanya J Shaw, Kazuo Kishi, Ryoichi MoriEndocrine, Metabolic & Immune Disorders Drug Targets|June 23, 2007
Novel therapeutic targets for diabetic nephropathyK Fukami, S Yamagishi, S Ueda, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 23, 2007
Development of novel compounds to treat autoimmune and inflammatory diseases and graft versus host reactionsS Appel, P BrossartEndocrine, Metabolic & Immune Disorders Drug Targets|June 23, 2007
CXCR3 axis: role in inflammatory bowel disease and its therapeutic implicationUdai P Singh, Chandrasekar Venkataraman, Rajesh Singh, et al.Endocrine, Metabolic & Immune Disorders Drug Targets|June 23, 2007
Readjusting the glucocorticoid balance: an opportunity for modulators of 11beta-hydroxysteroid dehydrogenase type 1 activity?Atanas G Atanasov, Alex OdermattEndocrine, Metabolic & Immune Disorders Drug Targets|August 12, 2011
Gender differences in metabolic syndrome: a key research issue?Abishek Iyer, Kathleen Kauter, Lindsay BrownEndocrine, Metabolic & Immune Disorders Drug Targets|August 12, 2011
The fetal origins of obesity: early origins of altered food intakeB S Muhlhausler, Z Y OngEndocrine, Metabolic & Immune Disorders Drug Targets|August 22, 2018
Genetic Polymorphisms of Cytochrome p450 (2C9) Enzyme in Patients with Type 2 Diabetes Mellitus in Turkmen and Fars Ethnic GroupsMina Rabiee, Abdoljalal Marjani, Safoura Khajeniazi, et al.Pageof 201